Hempacco Co., Inc. (HPCO)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.54 Million USD | 294.13% |
| 2022 | 645.13 Thousand USD | 224.29% |
| 2021 | 198.93 Thousand USD | 114.6% |
| 2020 | 92.69 Thousand USD | -85.51% |
| 2019 | 639.66 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q1 | 812.64 Thousand USD | 25.97% |
| 2023 FY | 2.54 Million USD | 294.13% |
| 2023 Q4 | 2.54 Million USD | 179.49% |
| 2023 Q3 | 909.75 Thousand USD | -23.0% |
| 2023 Q2 | 1.18 Million USD | 45.39% |
| 2022 Q3 | 798.5 Thousand USD | 53.46% |
| 2022 Q4 | 645.13 Thousand USD | -19.21% |
| 2022 FY | 645.13 Thousand USD | 224.29% |
| 2022 Q1 | 619.04 Thousand USD | 211.18% |
| 2022 Q2 | 520.32 Thousand USD | -15.95% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | 198.93 Thousand USD | 114.6% |
| 2021 Q4 | 198.93 Thousand USD | 16.52% |
| 2021 Q3 | 170.72 Thousand USD | 0.0% |
| 2020 FY | 92.69 Thousand USD | -85.51% |
| 2020 Q4 | 92.69 Thousand USD | 0.0% |
| 2019 FY | 639.66 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Journey Medical Corporation | 10.2 Million USD | 75.087% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 97.713% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | 62.437% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 97.563% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 55.663% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 55.663% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| Safety Shot Inc | 1.86 Million USD | -35.995% |
| Alpha Teknova, Inc. | 11.59 Million USD | 78.069% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | 92.136% |
| Bright Green Corporation | - USD | -Infinity% |
| Dynavax Technologies Corporation | 53.29 Million USD | 95.229% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 96.125% |
| Cosmos Health Inc. | 4.78 Million USD | 46.908% |
| PainReform Ltd. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -213.999% |
| Embecta Corp. | 152.1 Million USD | 98.328% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | 78.169% |
| Procaps Group, S.A. | 96.83 Million USD | 97.374% |
| Theratechnologies Inc. | 6.06 Million USD | 58.084% |
| Harrow Health, Inc. | 10.86 Million USD | 76.602% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | 6.487% |
| Biofrontera Inc. | 10.9 Million USD | 76.69% |
| DURECT Corporation | 2.21 Million USD | -14.584% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 96.715% |
| Cronos Group Inc. | 30.33 Million USD | 91.619% |
| OptiNose, Inc. | 8.05 Million USD | 68.422% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -254262700.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | 55.385% |
| Organogenesis Holdings Inc. | 28.25 Million USD | 91.001% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | 5.023% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | 44.838% |
| Radius Health, Inc. | 278.64 Million USD | 99.087% |
| Universe Pharmaceuticals INC | 3.34 Million USD | 23.948% |
| ProPhase Labs, Inc. | 3.84 Million USD | 33.803% |
| Phibro Animal Health Corporation | 265.91 Million USD | 99.044% |
| Procaps Group S.A. | 96.83 Million USD | 97.374% |
| Alvotech | 74.43 Million USD | 96.584% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 99.927% |
| Rockwell Medical, Inc. | 5.87 Million USD | 56.692% |
| Aytu BioPharma, Inc. | 12.63 Million USD | 79.873% |
| SIGA Technologies, Inc. | 64.21 Million USD | 96.041% |
| Tilray Brands, Inc. | 252.08 Million USD | 98.991% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | 93.64% |
| Shineco, Inc. | 1.58 Million USD | -60.062% |
| PetIQ, Inc. | 159.3 Million USD | 98.404% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 1764.263% |
| Incannex Healthcare Limited | -10.01 Million USD | 125.388% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | 93.361% |
| Alimera Sciences, Inc. | 1.87 Million USD | -35.318% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | 93.253% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -57.889% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | 43.283% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -899.649% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | 75.505% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | 96.584% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 94.68% |
| Lantheus Holdings, Inc. | 64.02 Million USD | 96.029% |
| Currenc Group, Inc. | 732.91 Thousand USD | -246.922% |
| Kamada Ltd. | 87.74 Million USD | 97.102% |
| Indivior PLC | 141.79 Million USD | 98.207% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -427.691% |
| Flora Growth Corp. | 8.5 Million USD | 70.115% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -899.649% |
| Evolus, Inc. | 10.99 Million USD | 76.881% |
| HUTCHMED (China) Limited | 50.25 Million USD | 94.941% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 97.598% |
| Akanda Corp. | 1.28 Million USD | -97.579% |